ArticleBMC biology2026
BiToxNet: a deep learning framework integrating multimodal features for accurate identification of neurotoxic peptides and proteins.
Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAccurate prediction of the neurotoxicity of peptides and proteins is critically important for the safety assessment of protein therapeutics and the development of protein-based drugs. Although experimental methods can reliably identify neurotoxic peptides and neurotoxins, they are labor-intensive, costly, and unsuitable for large-scale screening. Existing computational approaches are often limited by shallow feature engineering and suboptimal multimodal fusion strategies, which restrict their predictive accuracy and generalizability in real-world applications.
resultsIn this study, we propose BiToxNet, a deep learning framework that integrates evolutionary embeddings derived from a protein large language model with ten handcrafted biochemical descriptors through a bilinear attention network (BAN). This design enables effective modeling of cross-modal interactions and residue-level dependencies critical for neurotoxicity prediction. BiToxNet was evaluated on three datasets of different sequence lengths, namely Protein, Peptide, and Combined datasets, achieving accuracies of 92.3%, 96.0%, and 92.7%, respectively, and consistently outperforming existing state-of-the-art methods. Ablation studies confirmed the importance of both evolutionary embeddings and handcrafted features, as well as the critical role of BAN in feature fusion. Visualization analyses using t-SNE and hierarchical clustering further demonstrated that BiToxNet learns highly discriminative representations without reliance on domain-specific prior knowledge. Additional evaluation on an external imbalanced dataset validated the robustness and strong generalization capability of the proposed framework.
conclusionsOverall, BiToxNet provides a powerful and generalizable computational framework for the accurate identification of neurotoxic peptides and proteins. By effectively integrating evolutionary and biochemical information through bilinear attention, BiToxNet offers a valuable tool for neurotoxin screening and protein drug safety assessment, and presents a distinctive modeling strategy applicable to a wide range of biological sequence analysis tasks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.